Point72 Hong Kong LTD Reata Pharmaceuticals Inc Transaction History

Point72 Hong Kong LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$20.71 - $36.5 $9,505 - $16,753	459 New	459 $14,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $10,602 - $45,937	-414 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$100.0 - $143.02 $3,700 - $5,291	37 Added 9.81%	414 $42,000
Q2 2021 Aug 16, 2021	SELL	$78.27 - $151.29 $150,513 - $290,930	-1,923 Reduced 83.61%	377 $53,000
Q1 2021 May 17, 2021	BUY	$94.25 - $132.81 $64,749 - $91,240	687 Added 42.59%	2,300 $229,000
Q4 2020 Feb 16, 2021	BUY	$102.03 - $184.62 $164,574 - $297,792	1,613 New	1,613 $199,000
Q3 2020 Nov 16, 2020	SELL	$93.53 - $163.34 $61,168 - $106,824	-654 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $82,600 - $115,470	654 New	654 $102,000
Q3 2019 Nov 14, 2019	SELL	$71.26 - $95.75 $11,971 - $16,086	-168 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$77.72 - $94.35 $11,113 - $13,492	143 Added 572.0%	168 $16,000
Q1 2019 May 15, 2019	BUY	$51.9 - $101.79 $1,297 - $2,544	25 New	25 $2,000
Q4 2018 Feb 14, 2019	SELL	$48.76 - $76.44 $22,332 - $35,009	-458 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$35.64 - $92.06 $4,811 - $12,428	-135 Reduced 22.77%	458 $37,000
Q2 2018 Aug 14, 2018	BUY	$19.94 - $40.96 $11,824 - $24,289	593 New	593 $21,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.